MINDCURE Successfully Completes First Stage of Manufacturing Synthetic Ibogaine for Use in Psychedelic Clinical Research Jun 3, 2021
Cybin Files an International Patent Application Further Strengthening its Psychedelic Derivative Drug Development… May 26, 2021